About
Briacell Therapeutics Corp (TO:BCT) — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
BriaCell Announces Six Clinical Data Presentations at ASCO 2026
Apr 21 2026
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+(TM) in Preclinical Cancer Models
Apr 20 2026
BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting
Mar 31 2026
BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License
Mar 18 2026
BriaCell to Present Positive Clinical Data for Bria-IMT(TM) and Preclinical Data for Next Generation Bria-OTS+(TM) Personalized Immunotherapy at the 2026 AACR Conference
Financials
Revenue
CA$0
Market Cap
CA$40.89 M
EPS
-20.05
Translate